Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL

Journal of Clinical Investigation

Volumn 98, Issue 8, 1996, Pages 1788-1793

  Ramachandra, Sumant ^a   Metcalf, Robert A ^b   Fredrickson, Torg ^b   Marti, Gerald E ^b   Raveche, Elizabeth ^a,c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

B 1 cell; B CLL; CD5+B cell; IL 10; lymphoproliferation

Indexed keywords

IMMUNOGLOBULIN M; INTERLEUKIN 10;

ANEMIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL TRANSFORMATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTOSIS;

EID: 0029911105     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118978     Document Type: Article

References (34)

1. Rozman, C., and E. Montserrat. 1995. Chronic lymphocytic leukemia. N. Engl. J. Med. 333:1052-1057.
2. Phillips, J., K. Mehta, C. Fernandez, and E. Raveche. 1992. The NZB mouse as a model for CLL. Cancer Res. 52:437-443.
3. Stall, A., M. Farinas, D. Tarlinton, P. Lalor, L. Herzenberg, S. Strober, and L. Herzenberg. 1988. Ly-1 B cell clones similar to human CLL routinely develop in older normal mice and young autoimmune NZB related animals. Proc. Natl. Acad. Sci. USA. 85:7312-7316.
4. Okamoto, H., H. Nishimura, A. Shinozaki, D. Zhang, S. Hirose, and T. Shirai. 1993. H-2z homozygous New Zealand mice as a model for B cell chronic lymhocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages. Jpn. J. Cancer Res. 84:1273.
5. Peng, B., N. Mehta, H. Fernandes, C. Chou, and E. Raveche. 1995. Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide. Leuk. Res. 19:159-167.
6. Finke, J., P. Ternes, W. Lange, R. Mertelsmann, and G. Dolken. 1993. Expression of IL-10 in B lymphocytes of different origin. Leukemia (Baltimore). 7:1852-1857.
7. Masood, R., Y. Zhang, M. Bond, D. T. Scadden, T. Moudgil, R. Law, M. Kaplan, B. Jung, B. Espina, Y. Lunardi-Iskandar, et al. 1995. IL-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B cell lymphoma. Blood. 85:3423-3430.
8. Fernandes, H., W. Barchuk, S. Ramachandra, C. Chou, G. Fernandes, and E. Raveche. 1995. Regulation of CLL by IL-10: Role of antisense IL-10. Oncol. Rep. 2:985-989.
9. Fluckiger, A., P. Garrone, I. Durand, J. Galizzi, and J. Banchereau. 1993. IL-10 upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J. Exp. Med. 178:1473-1481.
10. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22:711-717.
11. Benjamin, D., T.J. Knobloch, and M.A. Dayton. 1992. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood. 80:1289-1298.
12. Miyazaki, I., R.K. Cheung, and H.M. Dosch. 1993. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med. 178:439-447.
13. Morel, L., U. Rudofsky, J. Longmate, J. Schiffenbauer, and E. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1:219-229.
14. Kono, D., R. Burlingame, D. Owens, A. Kuramochi, R. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA. 91:10168-10172.
15. Drake, C., S. Rozzo, H. Hirschfeld, N. Smarnworaworg, F. Palmer, and B. Kotzin. 1995. Analysis of the NZB contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J. Immunol. 154:2441-2447.
16. Raveche, E., E. Novotny, C. Hansen, J. Tjio, and A. Steinberg, 1981. Genetic studies in NZB mice V. Recombinant inbred lines demonstate that separate genes control autoimmune phenotype. J. Exp. Med. 153:1187-1197.
17. Raveche, E., J. Phillips, F. Mahboudi, A. Dang, H. Fernandes, S. Ramachandra, T. Lin, and B. Peng. 1992. Regulatory aspects of clonally expanded B-1 cells. Int. J. Clin. Lab. Res. 22:220-234.
18. Raveche, E.S., J.H. Tjio, and A.D. Steinberg. 1979. Genetic studies in NZB mice II. Hyperdiploidy in the spleen of NZB and their hybrids. Cytogenet. Cell Genet. 23:182-193.
19. Raveche, E.S., A.D. Steinberg, L.W. Klassen, and J.H. Tjio. 1978. Genetic studies in NZB mice. I Spontaneous autoantibody production. J. Exp. Med. 147:1487-1502.
20. Peng, B., D.H. Sherr, F. Mahboudi, J. Hardin, L. Sharer, and E.S. Raveche. 1994. A cultured malignant B-1 line serves as a model for Richter's syndrome. J. Immunol. 19:159-167.
21. Dang, A., M. Balasubramanyam, Z. Garcia, J. Gardner, and E. Raveche. 1995. Altered calcium signal transduction in B-1 malignant cells. Immunol. Cell Biol. 73:511-520.
22. Cortes, J.E., M. Talpaz, F. Cabanillas, J.F. Seymour, and R. Kurzrock. 1995. Serum levels of IL-10 in patients with diffuse large cell lymphoma: Lack of correlation with prognosis. Blood. 85:2516-2520.
23. Knauf, W., B. Ehlers, S. Bisson, and E. Thiel. 1995. Serum levels of IL-10 in B-CLL. Blood. 86:4382-4386.
24. Mercolino, T., B. Herndier, T. Nolan, and M. McGrath. 1992. Large cell "mixed phenotype" lymphoma in AIDS. Ann. NY Acad. Sci. 651:409-421.
25. Ng, V.L., M.H. Hurt, B.G. Herndier, and M.S. McGrath. 1995. VH gene use by CD5+ AIDS-associated B-cell lymphoproliferations. Ann. NY Acad. Sci. 764:507-508.
26. Sjoberg, J., M. Aguilar-Santelises, A.M. Sjogren, E.K. Pisa, A. Ljundgdahl, M. Bjorkholm, M. Jondal, H. Mellstedt, and P. Pisa. 1996. IL-10 mRNA expression in B-CLL inversely correlates with progression of disease. Br. J. Haematol. 92:393-400.
27. Mignon-Godefroy, K., O. Rott, M. Brazillet, and J. Charreire. 1995. Curative and protective effects of IL-10 in experimental autoimmune thryroiditis. J. Immunol. 154:6634-6643.
28. Ishida, H., T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon, and M. Howard. 1994. Continuous administration of anti-IL-10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305-310.
29. Ranheim, E.A., M.J. Cantwell, and T.J. Kipps. 1995. Expression of CD27 and its ligand. CD70, on CLL B cells. Blood. 85:3556-3565.
30. Neurath, M.F., E.R. Stuber, and W. Strober. 1995. BSAP: a key regulator of B cell development and differentiation. Immunol. Today. 16:564-569.
31. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. IL-10 deficient mice develop chronic enterocolitis. Cell. 75:263-274.
32. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D.H. Hsu, R. Kastelein, K.W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA. 89:1890-1893.
33. Bost, K.L., S.C. Bieligk, and B.M. Jaffe. 1995. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. J. Immunol. 154:718-729.
34. Panayiotidis, P., K. Ganeshaguru, L. Foroni, and A. Hoffbrand. 1995. Expression and function of fas antigen in B-CLL and Hairy cell leukemia. Leukemia (Baltimore). 9:1227-1232.